Inactive Instrument

News Innate Immunotherapeutics Ltd Australian S.E.

Equities

AU000000IIL6

Summary

Unlock all the news: Be the first to know and act before the market!

Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-30	CI
Amplia Therapeutics Completes AU$4.27 Million Entitlement Offer; Shares Up 9%	05-15	MT
Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing	04-16	MT
Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II	03-27	MT
Amplia Therapeutics Updates on Pancreatic Cancer Trial; Phase-Two Recruitment Ongoing; Shares Up 3%	03-27	MT
Amplia Therapeutics moves to next phase of pancreatic cancer treatment trial	02-14	AQ
Amplia Therapeutics Secures US FDA Clearance for Proposed Pancreatic Cancer Trial	01-18	MT
Amplia Therapeutics Limited Announces FDA Clearance of it's IND for Pancreatic Cancer Trial in US	01-18	CI
Amplia Therapeutics Doses First Patient in Phase 2A Pancreatic Cancer Trial	01-17	MT
Amplia Therapeutics Secures South Korean Regulatory Approval for Pancreatic Cancer Trial; Shares Up 3%	12-04	MT
Amplia Therapeutics Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-20	CI
Amplia Therapeutics Receives AU$2.4 Million R&D Tax Rebate	19/10/23	MT
Amplia Therapeutics Appoints CFO	25/09/23	MT
Amplia Therapeutics Limited Announces Chief Financial Officer Changes	24/09/23	CI
Amplia Therapeutics Gets Nod to Name Drug AMP945 Narmafotinib	23/06/23	MT
Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23	CI
Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt	29/05/23	CI
Amplia secures funding to assess AMP945 topical applications	22/05/23	AQ
Amplia Therapeutics to Enter Research Collaboration with CSIRO; Shares Rise 7%	22/05/23	MT
Amplia Receives Grant to Collaborate with CSIRO	21/05/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Innate Immunotherapeutics Ltd Australian S.E.

Equities

AU000000IIL6

Summary

Filters